Kidney Stone Risk and Your Genetics

Kidney stone risk, known medically as nephrolithiasis susceptibility, reflects an individual's inherited predisposition to forming calcium, oxalate, or uric acid crystals within kidney tubules. Genome-wide research has identified genetic variants near RGS14, SLC34A1, and AQP1—genes involved in renal G-protein signaling, phosphate transport, and water channel function—as among those reproducibly associated with kidney stone susceptibility. This page covers what genetics reveals about kidney stone biology, the renal pathways involved, and how lifestyle and dietary factors interact with inherited risk.

What is kidney stone risk?

Kidney stones form when dissolved minerals and salts in urine become concentrated and crystallize within the renal collecting system. The most common types are calcium oxalate stones—accounting for the majority of cases—followed by calcium phosphate, uric acid, and less frequently struvite or cystine stones. When a stone grows large enough or moves through the ureter, it can cause intense, wave-like pain, blood in urine, nausea, and urinary urgency.

Population studies consistently find that kidney stones cluster in families. Twin research has demonstrated that genetic factors make a meaningful contribution to individual variation in nephrolithiasis susceptibility, with inheritance reflecting multiple pathways including urinary calcium excretion, oxalate handling, uric acid metabolism, and kidney tubule transport function. No single gene causes kidney stones; instead, multiple common variants each contribute modestly to overall polygenic liability.

Nephrolithiasis is among the more prevalent urological conditions in adults worldwide, with genetic factors estimated to contribute substantially to individual differences in susceptibility. Genome-wide research has identified specific chromosomal regions—including loci near RGS14, SLC34A1, and AQP1—where common variants are reproducibly associated with kidney stone risk across diverse populations. [1]

Your ExomeDNA genetic profile captures variation at these well-characterized loci, offering a window into the inherited component of your kidney stone risk. This genetic information is most useful when combined with dietary history, hydration habits, and prior stone history.

Research base: Moderate.

The genetics behind kidney stone risk

Genome-wide analysis has identified several gene candidates at loci associated with kidney stone susceptibility:

RGS14 (regulator of G-protein signaling 14) emerges as the top genetically prioritized gene at the chromosome 5 susceptibility locus. RGS14 modulates G-protein coupled receptor signaling pathways in kidney epithelial cells, influencing intracellular calcium handling and tubular transport regulation. G-protein signaling in the kidney proximal tubule and distal nephron governs key aspects of calcium and phosphate reabsorption—processes directly relevant to stone-forming mineral accumulation.

SLC34A1 (solute carrier family 34 member 1) encodes the primary sodium-phosphate cotransporter expressed in the kidney proximal tubule. This transporter reclaims phosphate from the glomerular filtrate before it reaches distal nephron segments where stone-forming minerals become concentrated. SLC34A1 variants have been linked to disorders of phosphate and calcium homeostasis—including conditions associated with elevated urinary calcium and kidney stone formation. Pathogenic variants in this gene cause rare forms of hypercalciuria and nephrolithiasis, lending strong biological plausibility to its presence in kidney stone genomic signals.

AQP1 (aquaporin-1) encodes the primary water channel protein in the kidney proximal tubule and thin descending limb of the loop of Henle. Water reabsorption along these segments concentrates tubular fluid as it travels toward the collecting duct. Impaired AQP1 function can alter the concentration gradient that determines whether stone-forming minerals precipitate in tubular fluid. Genetic variation near AQP1 may subtly influence urine concentrating capacity.

DGKH (diacylglycerol kinase eta) encodes an enzyme involved in intracellular diacylglycerol and phosphatidic acid signaling. DAG kinase signaling is active in renal epithelial cell types and may contribute to intracellular calcium regulation downstream of G-protein coupled receptor activation—connecting it mechanistically to the RGS14 pathway.

Additional genes in associated genomic regions—including F12 (coagulation factor XII) and INMT—may contribute to these loci, though the evidence for kidney-specific mechanisms is strongest for RGS14, SLC34A1, and AQP1.

What the research says

Genome-wide studies of nephrolithiasis have expanded from single-institution candidate gene approaches to large population cohorts, revealing a polygenic landscape where multiple loci each contribute modestly to overall risk.

SLC34A1 encodes the principal sodium-phosphate cotransporter in the kidney proximal tubule, responsible for reclaiming phosphate from filtered urine. Variants affecting this transporter have been linked to dysregulated phosphate and calcium handling—a pathway directly relevant to calcium-based stone formation, the most common kidney stone type. [1]

Calcium handling genes consistently emerge from kidney stone genome-wide studies. The proximal tubule, where phosphate and calcium reabsorption is most active, is a key site of genetic influence on stone risk. Variants affecting transporters like SLC34A1 or signaling regulators like RGS14 at this nephron segment can shift the balance of tubular mineral concentrations in ways that promote or resist crystal nucleation.

Water handling and urine concentration are recognized risk factors for stone formation. Chronically low urine volume—from inadequate fluid intake or high insensible fluid losses—is one of the most modifiable stone risk factors. Genetic variation affecting aquaporin water channels may modulate baseline urine concentrating capacity, establishing a biological context within which hydration habits interact with inherited risk.

Polygenic risk means that kidney stone susceptibility reflects the combined effect of many common variants plus behavioral factors. The most robust single predictors of stone recurrence are dietary habits (particularly sodium, animal protein, and oxalate intake), hydration status, and prior stone history—genetic profiling adds biological context to these established risk factors.

How kidney stone risk affects you

Genetic susceptibility to kidney stones establishes a biological predisposition that dietary, hydration, and lifestyle factors substantially modify. For individuals without prior stone history, understanding genetic risk can motivate proactive dietary and hydration habits. For those with a history of kidney stones, genetic information adds biological context to clinician conversations about recurrence prevention.

The most relevant genetic dimensions captured here—phosphate transport (SLC34A1), water channel function (AQP1), and G-protein signaling regulation (RGS14)—all converge on the same fundamental risk mechanism: elevated urinary concentration of stone-forming minerals. Whether through reduced phosphate reclamation, altered calcium homeostasis, or subtly impaired urine dilution capacity, the result is a microenvironment in the kidney tubule more permissive to crystal nucleation.

Individuals with higher genetic susceptibility may require lower urinary mineral concentrations to avoid stone formation than those without this genetic background—making consistent high fluid intake a particularly important behavioral priority.

Prior stone type matters for risk management. Calcium oxalate stones involve different dietary levers than uric acid or calcium phosphate stones. Genetic information about specific pathway involvement can guide which biochemical measurements a urologist or nephrologist may want to monitor over time.

Working with your kidney stone genetic profile

Kidney stone prevention has among the best-established evidence bases in preventive urology, with several behavioral modifications shown to meaningfully reduce recurrence risk even in genetically susceptible individuals:

High fluid intake is the single most effective intervention for reducing kidney stone risk across all stone types and genetic backgrounds. Maintaining daily urine output of at least 2 to 2.5 liters substantially reduces urinary mineral concentration. For individuals with SLC34A1 or AQP1 susceptibility variants, prioritizing consistent hydration is especially relevant.

Dietary sodium reduction lowers urinary calcium excretion, directly reducing the driving force for calcium stone formation. High sodium intake is among the most reliably identified dietary risk factors for calcium stone recurrence, independent of total calcium intake.

Appropriate dietary calcium from food is counterintuitive but well-supported: adequate calcium from food sources binds oxalate in the gut, reducing urinary oxalate excretion—a major driver of calcium oxalate stones. Dairy or calcium-rich plant foods with meals provide more stone protection than calcium supplements taken separately.

Limiting high-oxalate foods (spinach, nuts, chocolate, beets) during meals without adequate calcium can raise urinary oxalate. For individuals with a history of calcium oxalate stones, pairing oxalate-containing foods with adequate dietary calcium is more effective than total restriction.

Animal protein moderation reduces urinary uric acid and promotes a less acid urine pH, both of which reduce risk for uric acid stone formation. Individuals with higher genetic susceptibility to metabolic stone-forming pathways may benefit from attention to animal protein load.

Regular monitoring—urine stone risk panels measuring 24-hour urinary levels of calcium, oxalate, citrate, uric acid, and creatinine—can help identify which specific biochemical drivers are active in individuals with stone history or elevated genetic risk.

Related traits and genes

Kidney stone genetics connects to several adjacent biological domains:

Uric acid metabolism — uric acid stone formation shares genetic architecture with gout and hyperuricemia, involving purine metabolism genes.

Calcium regulation — urinary calcium excretion is a central determinant of calcium stone risk, with shared genetic components in calcium transport pathways.

Kidney function markers — long-term kidney stone burden can affect glomerular filtration, linking nephrolithiasis susceptibility to broader kidney health genetics.

Vitamin D metabolism — vitamin D regulates intestinal calcium absorption and renal calcium handling, with genetic overlap in calcium stone risk in some populations.

Blood pressure regulation — renal sodium and calcium handling genes appear across both kidney stone and blood pressure genome-wide studies, reflecting shared tubular biology.

The SLC34A1 gene has also been studied in relation to hypophosphatemia and vitamin D metabolism disorders. For more on the genetics of renal mineral handling, visit the SLC34A1 gene page. Learn how ExomeDNA interprets genetic research at our methodology page, and explore our approach to genetic science with ExomeDNA Founder Scott Peeples.

Frequently asked questions

Does this genetic result mean I will form kidney stones? No. This result indicates that common genetic variants associated with kidney stone susceptibility at the population level are present in your profile. Population-level associations are probabilistic—many individuals with these variants never form kidney stones, particularly with adequate hydration and attention to dietary stone risk factors. Genetic susceptibility is one component of a multifactorial risk picture.

Which kidney stone types are most relevant to this genetic profile? The genes most strongly represented in this signal—SLC34A1 (phosphate transport), AQP1 (water handling), and RGS14 (calcium-relevant G-protein signaling)—point primarily toward calcium-based stone pathways (calcium oxalate and calcium phosphate), which account for the majority of kidney stones. Prior stone analysis, if available, provides the most direct information about which stone type is most relevant for individual risk management.

What is the most important lifestyle factor for preventing kidney stones? Fluid intake. Maintaining sufficient urine volume to keep urinary mineral concentrations below saturation thresholds is the most universally effective intervention across all stone types and genetic risk profiles. A practical target is maintaining pale yellow urine throughout the day, indicating sufficient dilution to reduce stone formation risk.

How does the SLC34A1 gene influence kidney stone risk? SLC34A1 encodes the primary sodium-phosphate cotransporter in the kidney proximal tubule—the section of the nephron most active in reclaiming filtered phosphate before it reaches concentrating segments. When this transporter's function is altered by genetic variation, phosphate reabsorption may be impaired, affecting urinary phosphate levels and downstream calcium-phosphate balance—a key determinant of calcium phosphate stone formation.

Should I discuss this result with my doctor? Genetic information about kidney stone risk is most useful in the context of clinical care if there is a personal or family history of kidney stones. A urologist or nephrologist can order a 24-hour urine stone risk panel, which directly measures which urinary factors are elevated in an individual's chemistry and guides targeted prevention strategies. Genetic results add biological context to this workup.

References

1. Genome-wide association study of nephrolithiasis susceptibility (2012). PMID: 22396660.

Data sources: GWAS Catalog, Open Targets Genetics, ClinVar, ClinGen, NCBI Gene, dbSNP.